Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 169 of the 169 references it cites were found in a registry or an index.

Should artificial intelligence be used in conjunction with Neuroimaging in the diagnosis of Alzheimer’s disease?

Open access
Mirkin, Sophia, Albensi, Benedict C. · 2023 · Frontiers in Aging Neuroscience

Abstract

Alzheimer’s disease (AD) is a progressive, neurodegenerative disorder that affects memory, thinking, behavior, and other cognitive functions. Although there is no cure, detecting AD early is important for the development of a therapeutic plan and a care plan that may preserve cognitive function and prevent irreversible damage. Neuroimaging, such as magnetic resonance imaging (MRI), computed tomography (CT), and positron emission tomography (PET), has served as a critical tool in establishing diagnostic indicators of AD during the preclinical stage. However, as neuroimaging technology quickly advances, there is a challenge in analyzing and interpreting vast amounts of brain imaging data. Given these limitations, there is great interest in using artificial Intelligence (AI) to assist in this process. AI introduces limitless possibilities in the future diagnosis of AD, yet there is still resistance from the healthcare community to incorporate AI in the clinical setting. The goal of this review is to answer the question of whether AI should be used in conjunction with neuroimaging in the diagnosis of AD. To answer the question, the possible benefits and disadvantages of AI are discussed. The main advantages of AI are its potential to improve diagnostic accuracy, improve the efficiency in analyzing radiographic data, reduce physician burnout, and advance precision medicine. The disadvantages include generalization and data shortage, lack of in vivo gold standard, skepticism in the medical community, potential for physician bias, and concerns over patient information, privacy, and safety. Although the challenges present fundamental concerns and must be addressed when the time comes, it would be unethical not to use AI if it can improve patient health and outcome.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3389/fnagi.2023.1094233

Cites

169 of 169 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 Legend: Patients present with neurocognitive symptoms ranging from noticeable memory loss, trouble performing routine tasks, confusion, personality changes, etc. A brain scan is performed in the clinic using the appropriate modality such as CT, MRI, or PET. The image is stored into the picture archiving and communication systems (PACS) database and processed into an artificial intelligence-based system to detect and sort low, moderate, and high priority brain scans. High priority cases are reviewed first by the radiologists followed by moderate and low cases. Once a diagnosis is made, the findings are compared with the AI database. If the radiologist’s decision does not match with the AI system, a second opinion is needed before making a definite diagnosis. Once a definite diagnosis is made, the patients can consult with their practitioner for future treatment recommendations.
Figure 1 Legend: Patients present with neurocognitive symptoms ranging from noticeable memory loss, trouble performing routine tasks, confusion, personality changes, etc. A brain scan is performed in the clinic using the appropriate modality such as CT, MRI, or PET. The image is stored into the picture archiving and communication systems (PACS) database and processed into an artificial intelligence-based system to detect and sort low, moderate, and high priority brain scans. High priority cases are reviewed first by the radiologists followed by moderate and low cases. Once a diagnosis is made, the findings are compared with the AI database. If the radiologist’s decision does not match with the AI system, a second opinion is needed before making a definite diagnosis. Once a definite diagnosis is made, the patients can consult with their practitioner for future treatment recommendations.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 168 references

Research works printed but not linked: 6

  1. Alickovic, 2020, For the Alzheimer’s Disease Neuroimaging Initiative, Subasi a. automatic detection of Alzheimer disease based on histogram and random forest, 91
  2. Neuroimaging Work, 2003, The use of MRI and PET for clinical diagnosis of dementia and investigation of cognitive impairment: a consensus Report
  3. 2018, Dementia: assessment, management and support for people living with dementia and their carers
  4. Herring, 2011, Learning radiology: Recognizing the basics E-book
  5. Kapoor, 2022, PET Scanning. StatPearls
  6. Ranzenberger, 2022, Diffusion tensor imaging. StatPearls

Cited by

See all 47

Metadata

Authors
Mirkin, S., & Albensi, B. C.
Affiliations
Nova Southeastern University (US)
Corresponding author
  • Mirkin, Sophia
  • Albensi, Benedict C.
Venue
Frontiers in Aging Neuroscience
Published
2023-04-18
Volume
15
Pages
1094233-1094233
ISSN
1663-4365 (ISSN-L)
OpenAlex
W4366291948
Cited by
46
References
168
Citations by year
2026: 5 · 2025: 24 · 2024: 14 · 2023: 3
FWCI
2.10
Type
journal article
Language
en
Open access
Locations
  • Frontiers in Aging Neuroscience (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
Canadian Institutes of Health Research (162144_1)
Topics
  • Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
  • Health Sciences › Medicine › Health Informatics › Artificial Intelligence in Healthcare and Education
  • Health Sciences › Health Professions › Health Information Management › Artificial Intelligence in Healthcare
Keywords
Alzheimer's disease, artificial intelligence, neuroimaging, early diagnosis, preclinical Alzheimer's disease, magnetic resonance imaging, PET, CT, AI-assisted image analysis, diagnostic accuracy, physician burnout, precision medicine, data scarcity, generalization, physician bias, patient privacy, clinical implementation of AI

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Should artificial intelligence be used in conjunction with Neuroimaging in the diagnosis of Alzheimer’s disease? https://app.cochat.ai/papers/10.3389/fnagi.2023.1094233
The paper
Mirkin, S., & Albensi, B. C. (2023). Should artificial intelligence be used in conjunction with Neuroimaging in the diagnosis of Alzheimer’s disease? Frontiers in Aging Neuroscience. https://doi.org/10.3389/fnagi.2023.1094233

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.